Details for New Drug Application (NDA): 214492
✉ Email this page to a colleague
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 214492
Tradename: | ZONISAMIDE |
Applicant: | Unichem |
Ingredient: | zonisamide |
Patents: | 0 |
Pharmacology for NDA: 214492
Mechanism of Action | Carbonic Anhydrase Inhibitors P-Glycoprotein Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 214492
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 214492 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-428 | 29300-428-01 | 100 CAPSULE in 1 BOTTLE (29300-428-01) |
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 214492 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-428 | 29300-428-05 | 500 CAPSULE in 1 BOTTLE (29300-428-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription